Form 4 for RGEN REPLIGEN CORP
Accepted 2022-07-22 00:00:00 ET · period of report 2022-07-21 · accession 0000899243-22-026581 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-07-22 | 2022-07-21 | RGEN | Hunt Anthony | CEO, Dir | M - OptEx | $32.76 | +20.2K | 219.5K | +10% | +$660.3K |
| D | 2022-07-22 | 2022-07-21 | RGEN | Hunt Anthony | CEO, Dir | S - Sale+OE | $200.00 | -24.8K | 194.7K | -11% | -$4.96M |
| DM | 2022-07-22 | 2022-07-21 | RGEN | Hunt Anthony | CEO, Dir | M - OptEx | $0.00 | +20.2K | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-21 | M | A | 5,000 | $33.87 | 204,315 | D | — | — | |
| 2 | Common | Common Stock | 2022-07-21 | S | D | 24,802 | $200.00 | 194,667 | D | — | — | |
| 3 | Common | Common Stock | 2022-07-21 | M | A | 15,154 | $32.40 | 219,469 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-07-21 | M | A | 5,000 | $0.00 | 69,246 | D | $33.87 · — to 2028-02-29 | 5,000 Common Stock | (F2) This option is fully vested and exercisable. |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-07-21 | M | A | 15,154 | $0.00 | 0 | D | $32.40 · — to 2027-02-23 | 15,154 Common Stock | (F2) This option is fully vested and exercisable. |